However, cotreatment with both MEC plus SB 203580 was more effective in further reducing tumor volumes as well as attenuating protein expression of both SOX2 and vimentin, suggesting a casual role of both nicotine and p38 MAPK in NIC plus HFD-induced breast tumor progression. This evidence concerns the gene SOX2 and breast neoplasm.